Welcome to our dedicated page for Aramark US SEC filings (Ticker: ARMK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Millions eat, heal, study, and cheer in venues run by Aramark. That reach translates into dense disclosures on food-cost inflation, long-term campus contracts, and the recent uniform-business spin-off. If you have ever searched for “Aramark insider trading Form 4 transactions” or wondered how a stadium caterer books revenue, you know the challenge: hundreds of pages, multiple exhibits, shifting segment names.
Stock Titan turns that sprawl into clarity. Our AI parses every 10-K and 10-Q the moment it hits EDGAR, flags labor-expense swings, and delivers a plain-English summary so “Aramark quarterly earnings report 10-Q filing” becomes a five-minute read. Need fast context on a surprise press release? We attach an “Aramark 8-K material events explained” card next to the source PDF. Real-time alerts surface “Aramark Form 4 insider transactions” so you can see when executives adjust holdings before new contract wins. Even the proxy—searchable under “Aramark proxy statement executive compensation”—is distilled to show incentive targets tied to food-service margins.
Everything is in one feed, updated instantly: annual report 10-K simplified, earnings report filing analysis, executive stock transactions Form 4, shelf registrations, and governance charters. Use it to compare segment performance across campuses and healthcare, monitor commodity-price hedges, or simply save hours understanding Aramark SEC documents with AI. Complex operations, explained simply—so you can focus on decisions, not document hunts.
Aramark, through its subsidiary Aramark Services, Inc., entered into Amendment No. 19 to its Credit Agreement to reprice its U.S. term debt. The company refinanced all outstanding U.S. Term B-8 Loans with new U.S. Term B-10 Loans totaling $2,384,140,862.90, maturing in June 2030, fully funded on December 11, 2025 and used to repay the prior tranche.
The new Term B-10 Loans bear interest at the company’s option at Term SOFR plus an initial margin of 1.75% or a base rate plus an initial margin of 0.75%. Principal repayments of $6,290,609.14 are required quarterly from December 31, 2028 through March 31, 2030, and the loans remain subject to substantially similar guarantees, collateral, prepayment provisions and covenants as the previous Term B-8 Loans.
Aramark executive reports routine share withholding for taxes. An Aramark executive, serving as EVP and General Counsel, reported a transaction dated 12/02/2025 under Form 4. The filing shows that 985.096 shares of Aramark common stock were disposed of at
Aramark executive SVP, Controller and Chief Accounting Officer reported a routine share transaction. On 12/02/2025, the insider had 337.782 shares of Aramark common stock withheld at a price of $37.08 per share to cover taxes due upon the vesting of restricted stock units. After this tax withholding, the reporting person beneficially owns 40,267.175 shares of Aramark common stock, held directly.
Aramark executive reports routine share withholding for taxes. An Aramark executive vice president and Chief HR Officer reported a Form 4 transaction dated 12/02/2025. The filing shows that 678.076 shares of Aramark common stock were withheld to cover taxes due on the vesting of restricted stock units at a price of $37.08 per share. After this tax-related transaction, the executive directly owns 81,172.534 shares of Aramark common stock. This reflects an administrative adjustment tied to equity compensation rather than an open-market buy or sell.
Aramark’s Chief Executive Officer reports a routine share withholding for taxes. On 12/02/2025, the CEO, who is also a director, had 5,467.695 shares of Aramark common stock withheld at a price of $37.08 per share. The filing explains that these shares were withheld to cover taxes due on the vesting of restricted stock units, rather than being an open‑market sale. Following this tax-related transaction, the CEO beneficially owned 1,017,262.358 shares of Aramark common stock directly.
Aramark filed a Form 4 reporting a routine equity transaction by its COO, U.S. Food & Facilities. On 12/02/2025, 1,116.373 shares of Aramark common stock were withheld at a price of $37.08 per share to cover taxes due on the vesting of restricted stock units. After this tax withholding, the executive beneficially owns 296,626.298 shares of Aramark common stock directly.
Aramark's Executive Vice President and Chief Financial Officer reported a routine equity transaction involving company stock. On 12/02/2025, the officer had 930.8 shares of common stock withheld at a price of $37.08 per share to cover taxes due on the vesting of restricted stock units. After this tax withholding, the officer beneficially owned 61,260.478 shares of Aramark common stock in direct ownership. This type of transaction does not represent an open-market buy or sell, but an administrative step related to equity compensation.
Aramark reported that its EVP & Chief HR Officer acquired additional equity on 12/01/2025. The executive received 9,440 restricted stock units of common stock at a reference price of $37.08 per share, increasing total beneficial ownership of common stock to 81,850.61 shares.
The same day, the executive was granted 33,708 stock options with an exercise price of $37.08 per share, exercisable for 33,708 shares of common stock and expiring on 12/01/2035. Both the restricted stock units and the options vest in four equal annual installments beginning on the first anniversary of the grant date, tying value to multi‑year service and performance.
Aramark reported an equity grant to one of its senior executives. On 12/01/2025, the SVP, Controller and CAO acquired 4,315 shares of common stock at a price of $37.08, increasing directly held common stock to 40,604.957 shares after the transaction. The filing also shows a grant of stock options covering 7,705 shares of common stock with an exercise price of $37.08 per share, expiring on 12/01/2035.
The 4,315 shares are in the form of restricted stock units that vest in four equal annual installments starting on the first anniversary of the grant date. The 7,705 stock options vest on the same four-year schedule, also in equal annual installments beginning one year after the grant. These awards are a form of long-term incentive compensation that ties the executive’s potential future value to Aramark’s share price over time.
Aramark executive vice president and CFO reported new equity awards in the company’s stock. On 12/01/2025, the officer acquired 9,440 shares of common stock as restricted stock units at a reference price of $37.08 per share, bringing direct beneficial ownership to 62,191.278 shares. These restricted stock units vest in four equal annual installments starting on the first anniversary of the grant date.
The officer also received a stock option award giving the right to buy 33,708 shares of common stock at an exercise price of $37.08 per share, expiring on 12/01/2035. The options vest in four equal annual installments beginning on the first anniversary of the grant date, tying the executive’s compensation more closely to Aramark’s long-term share performance.
FAQ
What is the current stock price of Aramark US (ARMK)?
What is the market cap of Aramark US (ARMK)?
